# Understanding APOL1-Mediated Kidney Disease Awareness Day

This resolution asks Congress to officially recognize the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day." It's not a law that creates new rules or programs—it's more like a formal statement of support to draw attention to a specific health issue that disproportionately affects Black Americans.

Here's what you need to know: Some people carry genetic mutations in a gene called APOL1 that significantly increases their risk of kidney disease. About 13 percent of Black Americans have these mutations in both copies of the gene, which means roughly one in five of them will develop kidney disease at some point. People with African ancestry, particularly from Western and Central Africa, are more likely to carry these genetic variants. The resolution points out that Black Americans make up 13 percent of the U.S. population but account for 30 percent of people with kidney failure—a stark health disparity that the resolution argues needs more attention and research.

The practical impact of this resolution is mainly awareness-focused. If passed, it would encourage Americans—especially those with African ancestry—to learn more about their kidney disease risk and consider genetic testing to find out if they carry the APOL1 mutations. For people who discover they have these mutations, there are concrete steps they can take to protect their kidneys: regular doctor visits, healthy eating, taking medications as prescribed, exercising daily, and avoiding smoking. The resolution also highlights that while there are currently no FDA-approved treatments specifically for APOL1-mediated kidney disease, more awareness and research funding could help develop new treatments in the future.